Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1301.0000 -20.50 (-1.55%)

NSE Jun 27, 2025 15:31 PM

27.55% Gain from 52W Low

Volume: 1.8M

Dr. Reddy's Laboratories Ltd.

06 Nov 2024

1301.00

-1.55%

Dr Reddy's Labs (HOLD): Healthy Q2; margins post gRevlimid LOE to remain wary

Hold: Dr. Reddy's Laboratories Ltd.

BOB Capital Markets Ltd.

Revenue/EBITDA earnings above our and street estimates. APAT ~46% above estimates. Estimates adjusted for JV and impairment cost

Dr. Reddy's Laborato.. has an average target of 1343.25 from 9 brokers.